{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:07Z","timestamp":1790915827003,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.neubiorev.2007.03.002","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T11:01:31Z","timestamp":1174042891000},"page":"920-931","source":"Crossref","is-referenced-by-count":113,"title":["GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder"],"prefix":"10.1016","volume":"31","author":[{"given":"Michael K.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Maw","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2007.03.002_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.mp.4001114","article-title":"A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19","volume":"7","author":"Badenhop","year":"2002","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-3223(02)01320-3","article-title":"Genome scan for susceptibility loci for schizophrenia and bipolar disorder","volume":"52","author":"Bailer","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60783-6","article-title":"The Yin-Yang of TCF\/beta-catenin signaling","volume":"77","author":"Barker","year":"2000","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.npp.1300911","article-title":"Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases","volume":"31","author":"Basta-Kaim","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/070674370304800703","article-title":"Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms","volume":"48","author":"Bauer","year":"2003","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib7","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000093947","article-title":"The full story of lithium. A tribute to Mogens Schou (1918\u20132005)","volume":"75","author":"Bech","year":"2006","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2003.10.021","article-title":"A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder","volume":"355","author":"Benedetti","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2004.11.022","article-title":"Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T\/C SNP","volume":"376","author":"Benedetti","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.mp.4001758","article-title":"The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia","volume":"11","author":"Benes","year":"2006","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2006.07.006","article-title":"The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways","volume":"79","author":"Beurel","year":"2006","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib13","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1046\/j.1471-4159.2000.0752401.x","article-title":"Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity","volume":"75","author":"Bijur","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2004.02.042","article-title":"Signaling by insulin-like growth factor 1 in brain","volume":"490","author":"Bondy","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0925-4773(99)00046-5","article-title":"Dishevelled: at the crossroads of divergent intracellular signaling pathways","volume":"83","author":"Boutros","year":"1999","journal-title":"Mechanisms of Development"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0006-3223(02)01404-X","article-title":"Low glial numbers in the amygdala in major depressive disorder","volume":"52","author":"Bowley","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(91)90241-P","article-title":"Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity","volume":"64","author":"Boyle","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib18","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.2174\/138161206777947650","article-title":"Efficacy and mechanisms of action of lithium augmentation in refractory major depression","volume":"12","author":"Bschor","year":"2006","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib19","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/bi970982t","article-title":"Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge","volume":"37","author":"Bullock","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib20","doi-asserted-by":"crossref","first-page":"33791","DOI":"10.1074\/jbc.M204861200","article-title":"Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation","volume":"277","author":"Carmichael","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib21","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1073\/pnas.96.15.8745","article-title":"Lithium activates the serine\/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons","volume":"96","author":"Chalecka-Franaszek","year":"1999","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib24","first-page":"495","article-title":"Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system","volume":"19","author":"Chong","year":"2004","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib25","series-title":"Lithium in Neuropsychiatry: The Comprehensive Guide","first-page":"381","article-title":"Potential use of lithium in neurodegenerative disorders","author":"Chuang","year":"2006"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1098\/rstb.1999.0399","article-title":"The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction","volume":"354","author":"Cohen","year":"1999","journal-title":"Philosophical Transactions of the Royal Society of London B Biological Sciences"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/386824a0","article-title":"Subgenual prefrontal cortex abnormalities in mood disorders","volume":"386","author":"Drevets","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.shk.0000238059.23837.68","article-title":"Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation","volume":"27","author":"Dugo","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1124\/mol.104.009308","article-title":"Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3\u03b2 inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure","volume":"67","author":"Eickholt","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib33","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","article-title":"The role of the extracellular signal-regulated kinase signaling pathway in mood modulation","volume":"23","author":"Einat","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.mp.4001729","article-title":"Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells","volume":"10","author":"Engl","year":"2005","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0003-9861(88)90089-6","article-title":"Phosphoserine as a recognition determinant for glycogen synthase kinase-3: phosphorylation of a synthetic peptide based on the G-component of protein phosphatase-1","volume":"267","author":"Fiol","year":"1988","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/0264-6021:3590001","article-title":"GSK3 takes centre stage more than 20 years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochemistry Journal"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib38","doi-asserted-by":"crossref","first-page":"43844","DOI":"10.1074\/jbc.M207265200","article-title":"The regulation of glycogen synthase kinase-3 nuclear export by Frat\/GBP","volume":"277","author":"Franca-Koh","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib39","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1128\/JVI.77.14.8019-8030.2003","article-title":"The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3\u03b2","volume":"7","author":"Fujimuro","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","article-title":"Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain","volume":"158","author":"Fukumoto","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S1461145704004535","article-title":"AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test","volume":"7","author":"Gould","year":"2004","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib42","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2174\/1389450110607011399","article-title":"Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders","volume":"7","author":"Gould","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2001.00495.x","article-title":"CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium","volume":"78","author":"Grimes","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/mcne.2002.1117","article-title":"Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons","volume":"20","author":"Hall","year":"2002","journal-title":"Molecular Cell Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbapap.2003.11.009","article-title":"Structure, regulation and function of PKB\/AKT\u2014a major therapeutic target","volume":"1697","author":"Hanada","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib46","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0028-3908(02)00217-4","article-title":"Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity","volume":"43","author":"Hashimoto","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0091-3057(95)00057-4","article-title":"Behavioral characteristics of SART-stressed mice in the forced swim test and drug action","volume":"51","author":"Hata","year":"1995","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1389450110607011435","article-title":"Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes","volume":"7","author":"Henriksen","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","article-title":"Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation","volume":"12","author":"Hughes","year":"1993","journal-title":"EMBO Journal"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2004.11.010","article-title":"Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death","volume":"48","author":"Jin","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib52","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","article-title":"Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus","volume":"55","author":"Kaidanovich-Beilin","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2005.08.020","article-title":"Transient activation of protein phosphatase 2A induced by electroconvulsive shock in the rat frontal cortex","volume":"390","author":"Kang","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib55","doi-asserted-by":"crossref","unstructured":"Karege, F., Perroud, N., Burkhardt, S., Schwald, M., Ballmann, E., La Harpe, R., Malafosse, A., 2006. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biological Psychiatry (in press).","DOI":"10.1016\/j.biopsych.2006.04.036"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1819.2007.01604.x","article-title":"Molecular genetics of bipolar disorder and depression","volume":"61","author":"Kato","year":"2007","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","article-title":"Mitochondrial dysfunction in bipolar disorder","volume":"2","author":"Kato","year":"2000","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0959-4388(02)00320-3","article-title":"The GSK3 beta signaling cascade and neurodegenerative disease","volume":"12","author":"Kaytor","year":"2002","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib60","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1176\/appi.ajp.161.10.1814","article-title":"High concordance of bipolar I disorder in a nationwide sample of twins","volume":"161","author":"Kieseppa","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1242\/jcs.01562","article-title":"Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3","volume":"118","author":"Kim","year":"2005","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/JMN:24:2:237","article-title":"Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha","volume":"24","author":"Kirshenboim","year":"2004","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(01)00625-6","article-title":"Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test","volume":"71","author":"Kitamura","year":"2002","journal-title":"Pharmacological and Biochemical Behavior"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib64","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0306-4522(02)00573-0","article-title":"Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities","volume":"116","author":"Kopnisky","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib66","unstructured":"Koros, E., Dorner-Ciossek, C., Mueller, E., Sams-Dodd, F., 2006. Glycogen synthase kinase (GSK-3\u03b2) signaling in schizophrenia. Abstract of the Society for Neuroscience Annual Meeting, 589.5."},{"key":"10.1016\/j.neubiorev.2007.03.002_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(00)00174-2","article-title":"Low GSK-3 activity in frontal cortex of schizophrenic patients","volume":"52","author":"Kozlovsky","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S1461145705006097","article-title":"Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex","volume":"9","author":"Kozlovsky","year":"2006","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2005.10.059","article-title":"No association of two common SNPs at position -1727 A\/T, -50 C\/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population","volume":"395","author":"Lee","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib70","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-5618.2002.40201.x","article-title":"Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection","volume":"4","author":"Li","year":"2002","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1461145706006547","article-title":"Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics","volume":"10","author":"Li","year":"2007","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib73","doi-asserted-by":"crossref","first-page":"30479","DOI":"10.1074\/jbc.M607468200","article-title":"Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation","volume":"281","author":"Liang","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib74","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1074\/jbc.M605178200","article-title":"Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival","volume":"282","author":"Liang","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib75","doi-asserted-by":"crossref","first-page":"14383","DOI":"10.1073\/pnas.96.25.14383","article-title":"Activation of a frizzled-2\/beta-adrenergic receptor chimera promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via Galphao and Galphat","volume":"96","author":"Liu","year":"1999","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib76","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0006-3223(03)00700-5","article-title":"Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis","volume":"54","author":"Madsen","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1471-4159.2002.00939.x","article-title":"BDNF-mediated signal transduction is modulated by GSK3\u03b2 and mood stabilizing agents","volume":"82","author":"Mai","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0070-2153(05)72002-0","article-title":"Dishevelled: a mobile scaffold catalyzing development","volume":"72","author":"Malbon","year":"2006","journal-title":"Current Topics in Developmental Biology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib79","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1111\/j.1440-1614.1999.00670.x","article-title":"Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness","volume":"33","author":"Manji","year":"1999","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib80","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1432-1033.1994.tb19037.x","article-title":"Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1","volume":"223","author":"Marin","year":"1994","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacological Science"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neulet.2006.05.001","article-title":"Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder","volume":"403","author":"Michelon","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib83","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2002.00918.x","article-title":"Alternative splicing isoform of tau protein kinase I\/glycogen synthase kinase 3beta","volume":"81","author":"Mukai","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jad.2006.04.030","article-title":"Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature","volume":"95","author":"Nasrallah","year":"2006","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4088\/JCP.v64n0108","article-title":"Nortriptyline for treatment-resistant depression","volume":"64","author":"Nierenberg","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2005.10.042","article-title":"Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder","volume":"394","author":"Nishiguchi","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib87","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","article-title":"Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium","volume":"24","author":"O\u2019Brien","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib88","doi-asserted-by":"crossref","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","article-title":"Glial reduction in the subgenual prefrontal cortex in mood disorders","volume":"95","author":"Ongur","year":"1998","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib89","doi-asserted-by":"crossref","first-page":"19929","DOI":"10.1074\/jbc.273.32.19929","article-title":"Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase\/Akt cell survival pathway","volume":"273","author":"Pap","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib90","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/BST0320803","article-title":"Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?","volume":"32","author":"Patel","year":"2004","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib91","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gde.2006.12.007","article-title":"The many ways of Wnt in cancer","volume":"17","author":"Polakis","year":"2007","journal-title":"Current Opinion in Genetic Development"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib93","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1523\/JNEUROSCI.5216-05.2006","article-title":"Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania","volume":"26","author":"Prickaerts","year":"2006","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib94","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib95","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s002130050846","article-title":"Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate","volume":"141","author":"Redrobe","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib96","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","article-title":"Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction","volume":"89","author":"Ren","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib97","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1523\/JNEUROSCI.4321-06.2007","article-title":"Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation","volume":"27","author":"Rockenstein","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(02)00307-X","article-title":"Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain","volume":"27","author":"Roh","year":"2003","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib99","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopsych.2004.10.039","article-title":"Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine","volume":"57","author":"Roh","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008385","article-title":"Lithium neuroprotection: molecular mechanisms and clinical implications","volume":"6","author":"Rowe","year":"2004","journal-title":"Expert Reviews in Molecular Medicine"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib101","unstructured":"Rowe, M., Wiest, C., Chuang, D.M., 2006. Histone deacetylase inhibitors valproate and pivanex in the forced swim test: strain dependent outcomes. Abstract of the Society for Neuroscience Annual Meeting. Abstract number 290.20."},{"key":"10.1016\/j.neubiorev.2007.03.002_bib102","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.2000.4169","article-title":"Lithium inhibits glycogen synthase kinase-3 by competition for magnesium","volume":"280","author":"Ryves","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib103","first-page":"489","article-title":"The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle","volume":"5","author":"Ryves","year":"2003","journal-title":"Progress in Cell Cycle Research"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-5618.2005.00194.x","article-title":"GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid","volume":"7","author":"Ryves","year":"2005","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1399-5618.2000.20306.x","article-title":"The treatment of bipolar depression","volume":"2","author":"Sachs","year":"2000","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib106","first-page":"720","article-title":"Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes","volume":"41","author":"Shaw","year":"1998","journal-title":"Genome"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib107","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0960-9822(02)70790-2","article-title":"Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells","volume":"6","author":"Stambolic","year":"1996","journal-title":"Current Biology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib108","doi-asserted-by":"crossref","first-page":"37526","DOI":"10.1074\/jbc.M502699200","article-title":"A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons","volume":"280","author":"Szatmari","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib109","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/15622970600554711","article-title":"Association study of the glycogen synthase kinase-3\u03b2 gene polymorphism with prophylactic lithium response in bipolar patients","volume":"7","author":"Szczepankiewicz","year":"2006","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000090704","article-title":"Association analysis of the GSK-3\u03b2 T-50C gene polymorphism with schizophrenia and bipolar disorder","volume":"53","author":"Szczepankiewicz","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-5793(99)01161-8","article-title":"A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin","volume":"458","author":"Thomas","year":"1999","journal-title":"FEBS Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2006.03.102","article-title":"Behavioral effects of short-term administration of lithium and valproic acid in rats","volume":"1093","author":"Tomasiewicz","year":"2006","journal-title":"Brain Research"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib113","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.122062299","article-title":"Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage","volume":"99","author":"Watcharasit","year":"2002","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib114","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00213-002-1341-6","article-title":"Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat","volume":"166","author":"Wegener","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib115","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bmcl.2004.09.013","article-title":"Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds","volume":"14","author":"Werstuck","year":"2004","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib116","doi-asserted-by":"crossref","first-page":"29147","DOI":"10.1074\/jbc.M002169200","article-title":"Glycogen synthase kinase 3beta negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1","volume":"275","author":"Xavier","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neubiorev.2007.03.002_bib117","doi-asserted-by":"crossref","first-page":"33067","DOI":"10.1074\/jbc.M212635200","article-title":"Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3","volume":"278","author":"Zhang","year":"2003","journal-title":"Journal of Biological Chemistry"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763407000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763407000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T05:17:31Z","timestamp":1556255851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763407000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0149763407000243"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2007.03.002","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}